Are Doctors the Best People to Manage Gout? Is There a Role for Nurses and Pharmacists?

Overview

Journal Curr Rheumatol Rep

Publisher Current Science

Specialty Rheumatology

Date 2018 Mar 9

PMID 29516289

Citations 1

Authors

Zahira Latif

Abhishek Abhishek

Affiliations

Soon will be listed here.

Abstract

To discuss alternate models of long-term gout management RECENT FINDINGS: Nurse-led care of gout appears to improve the uptake of and adherence to urate-lowering treatment in a research setting. Less impressive improvements were achieved with pharmacist-led remote management of gout; however, both strategies were more effective than usual primary care provider management of gout. Individualised education about gout, patient involvement in decision-making, and access to trained support in managing side-effects and gout flares can improve the uptake of fine and adherence to urate-lowering treatment. This may be best achieved with nurse-led care of gout. However, further research is required to evaluate if the model of nurse-led care of gout can be implemented in routine clinical practice and in different healthcare systems.

Citing Articles

Evaluation of urate-lowering therapy in hyperuricemia patients: a systematic review and Bayesian network meta-analysis of randomized controlled trials.

Lin Y, Lin S, Lin C, Wang S, Chang S Clin Rheumatol. 2020; 39(5):1633-1648.

PMID: 31965378 DOI: 10.1007/s10067-019-04893-8.

References

Goldfien R, Pressman A, Jacobson A, Ng M, Avins A . A Pharmacist-Staffed, Virtual Gout Management Clinic for Achieving Target Serum Uric Acid Levels: A Randomized Clinical Trial. Perm J. 2016; 20(3):15-234. PMC: 4991910. DOI: 10.7812/TPP/15-234. View

Kanji T, Gandhi M, Clase C, Yang R . Urate lowering therapy to improve renal outcomes in patients with chronic kidney disease: systematic review and meta-analysis. BMC Nephrol. 2015; 16:58. PMC: 4431373. DOI: 10.1186/s12882-015-0047-z. View

Briesacher B, Andrade S, Fouayzi H, Chan K . Comparison of drug adherence rates among patients with seven different medical conditions. Pharmacotherapy. 2008; 28(4):437-43. PMC: 2737273. DOI: 10.1592/phco.28.4.437. View

De Vera M, Marcotte G, Rai S, Galo J, Bhole V . Medication adherence in gout: a systematic review. Arthritis Care Res (Hoboken). 2014; 66(10):1551-9. DOI: 10.1002/acr.22336. View

Chen J, Lan J, Cheng C, Liang W, Lin H, Tsay G . Effect of Urate-Lowering Therapy on All-Cause and Cardiovascular Mortality in Hyperuricemic Patients without Gout: A Case-Matched Cohort Study. PLoS One. 2015; 10(12):e0145193. PMC: 4684295. DOI: 10.1371/journal.pone.0145193. View

Kuo C, Grainge M, Mallen C, Zhang W, Doherty M . Eligibility for and prescription of urate-lowering treatment in patients with incident gout in England. JAMA. 2014; 312(24):2684-6. DOI: 10.1001/jama.2014.14484. View

Singh J, Ramachandaran R, Yu S, Curtis J . Allopurinol use and the risk of acute cardiovascular events in patients with gout and diabetes. BMC Cardiovasc Disord. 2017; 17(1):76. PMC: 5348884. DOI: 10.1186/s12872-017-0513-6. View

Goldfien R, Ng M, Yip G, Hwe A, Jacobson A, Pressman A . Effectiveness of a pharmacist-based gout care management programme in a large integrated health plan: results from a pilot study. BMJ Open. 2014; 4(1):e003627. PMC: 3902202. DOI: 10.1136/bmjopen-2013-003627. View

Jordan K, Cameron J, Snaith M, Zhang W, Doherty M, Seckl J . British Society for Rheumatology and British Health Professionals in Rheumatology guideline for the management of gout. Rheumatology (Oxford). 2007; 46(8):1372-4. DOI: 10.1093/rheumatology/kem056a. View

10.

Vaccher S, Kannangara D, Baysari M, Reath J, Zwar N, Williams K . Barriers to Care in Gout: From Prescriber to Patient. J Rheumatol. 2015; 43(1):144-9. DOI: 10.3899/jrheum.150607. View

11.

Abhishek A, Valdes A, Zhang W, Doherty M . Association of Serum Uric Acid and Disease Duration With Frequent Gout Attacks: A Case-Control Study. Arthritis Care Res (Hoboken). 2016; 68(10):1573-7. DOI: 10.1002/acr.22855. View

12.

Abhishek A, Jenkins W, La-Crette J, Fernandes G, Doherty M . Long-term persistence and adherence on urate-lowering treatment can be maintained in primary care-5-year follow-up of a proof-of-concept study. Rheumatology (Oxford). 2017; 56(4):529-533. DOI: 10.1093/rheumatology/kew395. View

13.

Fields T, Rifaat A, Yee A, Ashany D, Kim K, Tobin M . Pilot study of a multidisciplinary gout patient education and monitoring program. Semin Arthritis Rheum. 2016; 46(5):601-608. PMC: 5837038. DOI: 10.1016/j.semarthrit.2016.10.006. View

14.

Fisher M, Rai S, Lu N, Zhang Y, Choi H . The unclosing premature mortality gap in gout: a general population-based study. Ann Rheum Dis. 2017; 76(7):1289-1294. DOI: 10.1136/annrheumdis-2016-210588. View

15.

Kuo C, Grainge M, Mallen C, Zhang W, Doherty M . Rising burden of gout in the UK but continuing suboptimal management: a nationwide population study. Ann Rheum Dis. 2014; 74(4):661-7. PMC: 4392307. DOI: 10.1136/annrheumdis-2013-204463. View

16.

Robinson P, Merriman T, Herbison P, Highton J . Hospital admissions associated with gout and their comorbidities in New Zealand and England 1999-2009. Rheumatology (Oxford). 2012; 52(1):118-26. DOI: 10.1093/rheumatology/kes253. View

17.

Popovich I, Lee A, Doyle A, McHaffie A, Clarke A, Reeves Q . A comparative MRI study of cartilage damage in gout versus rheumatoid arthritis. J Med Imaging Radiat Oncol. 2015; 59(4):431-435. DOI: 10.1111/1754-9485.12306. View

18.

Abhishek A, Roddy E, Doherty M . Gout - a guide for the general and acute physicians. Clin Med (Lond). 2017; 17(1):54-59. PMC: 6297580. DOI: 10.7861/clinmedicine.17-1-54. View

19.

Elliot A, Cross K, Fleming D . Seasonality and trends in the incidence and prevalence of gout in England and Wales 1994-2007. Ann Rheum Dis. 2008; 68(11):1728-33. DOI: 10.1136/ard.2008.096693. View

20.

Terawaki H, Nakayama M, Miyazawa E, Murata Y, Nakayama K, Matsushima M . Effect of allopurinol on cardiovascular incidence among hypertensive nephropathy patients: the Gonryo study. Clin Exp Nephrol. 2012; 17(4):549-53. DOI: 10.1007/s10157-012-0742-z. View